Point mutations at VP1 residue 99 or 100 in Theiler's virus alter its ability to induce demyelination, likely by disrupting virus-receptor interactions on neural cells.
No takes yet. Share an insight, caveat, or question.
VP1 99/100 mutations abolish demyelination in the Theiler’s murine model; leaves open whether analogous residues modulate human viral demyelination.
Lin et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: